Sanofi SNY shares are trading higher on Monday.
The company reported the first patient outside of the U.S. has been treated as part of a global clinical program evaluating Kevzara in patients hospitalized with severe COVID-19.
Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.
Sanofi is a pharmaceutical company headquartered in Paris, France.
Sanofi's shares were trading up 4.62% to $44.40 at time of publication. The stock has a 52-week high of $51.84 and a 52-week low of $37.62.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.